We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-13.92%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
-$341M
(-14%)
Cap. Flow
+$97.8M
Cap. Flow
% of AUM
4.49%
Top 10 Holdings %
Top 10 Hldgs %
35.92%
Holding
3,540
New
358
Increased
1,256
Reduced
1,110
Closed
245
Avg Time Held Equity + Options
3.1
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.3
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$39.1M |
| 2 |
SPDR Gold Trust
GLD
|
+$26.2M |
| 3 |
Ready Capital
RC
|
+$20.4M |
| 4 |
Corcept Therapeutics
CORT
|
+$16.9M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$16.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$20.7M |
| 2 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$14.1M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$7.79M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$6.54M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.29% |
| 2 | Technology | 12.73% |
| 3 | Financials | 8.79% |
| 4 | Healthcare | 8.35% |
| 5 | Communication Services | 4.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Relay Therapeutics
RLAY
$3.83B
| $0 | ﹤0.01% |
+12
| New | +$257 |
2022 Q2
0 quarters
|
|
3277
Regional Management Corp
RM
$320M
| $0 | ﹤0.01% |
+10
| New | +$443 |
2022 Q2
0 quarters
|
|
3278
Rimini Street
RMNI
$383M
| $0 | ﹤0.01% |
+48
| New | +$286 |
2022 Q2
0 quarters
|
|
|
RNAM
3279
DELISTED
Avidity Biosciences
RNAM
| $0 | ﹤0.01% |
+21
| New | +$312 |
2022 Q2
0 quarters
|
|
3280
Cartesian Therapeutics
RNAC
$199M
| $0 | ﹤0.01% |
3
| – | – |
2020 Q4
6 quarters
|
|
3281
Cohen & Steers REIT and Preferred and Income Fund
RNP
$885M
| $0 | ﹤0.01% |
3
| – | – |
2020 Q4
6 quarters
|
|
3282
Global X Renewable Energy Producers ETF
RNRG
$22.9M
| – | – |
-423
| Closed | -$20K | – |
|
3283
Renasant Corp
RNST
$3.61B
| – | – |
-30
| Closed | -$1K | – |
|
3284
ROBO Global Robotics & Automation Index ETF
ROBO
$1.93B
| – | – |
-211
| Closed | -$12K | – |
|
3285
Gibraltar Industries
ROCK
$1.16B
| $0 | ﹤0.01% |
+9
| New | +$367 |
2022 Q2
0 quarters
|
|
3286
Revolution Medicines
RVMD
$41B
| $0 | ﹤0.01% |
+13
| New | +$253 |
2022 Q2
0 quarters
|
|
3287
ProShares Short Russell2000
RWM
$144M
| – | – |
-3,063
| Closed | -$67K | – |
|
3288
Recursion Pharmaceuticals
RXRX
$2.32B
| $0 | ﹤0.01% |
+29
| New | +$194 |
2022 Q2
0 quarters
|
|
3289
Rayonier Advanced Materials
RYAM
$482M
| – | – |
-15
| Closed | – | – |
|
3290
Ryerson Holding Corp
RYZ
$1.39B
| $0 | ﹤0.01% |
5
| – | – |
2022 Q1
1 quarter
|
|
3291
Saic
SAIC
$5.59B
| $0 | ﹤0.01% |
1
-17
| -94% | -$1.49K |
2021 Q3
3 quarters
|
|
3292
EchoStar
ECHO
$24.5B
| – | – |
-63
| Closed | -$2K | – |
|
3293
Filana Therapeutics
FLNA
$35.4M
| $0 | ﹤0.01% |
10
| – | – |
2021 Q1
5 quarters
|
|
3294
Seacoast Banking Corp of Florida
SBCF
$3.11B
| $0 | ﹤0.01% |
+11
| New | +$368 |
2022 Q2
0 quarters
|
|
3295
Sally Beauty Holdings
SBH
$1.57B
| $0 | ﹤0.01% |
+10
| New | +$145 |
2022 Q2
0 quarters
|
|
3296
Schwab 1000 Index ETF
SCHK
$5.77B
| – | – |
-72
| Closed | -$1.43K | – |
|
3297
Stepan Co
SCL
$1.41B
| $0 | ﹤0.01% |
4
-10
| -71% | -$1.03K |
2021 Q1
5 quarters
|
|
3298
DELISTED
Steelcase
SCS
| $0 | ﹤0.01% |
43
-5
| -10% | -$58 |
2021 Q1
5 quarters
|
|
3299
Schrodinger
SDGR
$1.88B
| – | – |
-8
| Closed | -$215 | – |
|
3300
CALL
Sea Limited
SE
$59.3B
| – | – |
-600
| Closed | -$104K | – |
|
Similar funds
Parallel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Parallel Advisors held 3,540 positions worth $2.18B, down 14% from $2.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $97.8M of net new capital in Q2 2022, opening 358 new positions and adding to 1,256 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $20.7M trimmed.
- Parallel Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
- Parallel Advisors added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $39.1M increase.
- Parallel Advisors's biggest Q2 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $20.7M.
- Parallel Advisors fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $7.79M.
- Parallel Advisors's ten largest holdings make up 36% of its $2.18B portfolio in Q2 2022.
- Parallel Advisors opened 358 new positions and closed 245 in Q2 2022.
- Parallel Advisors's portfolio value fell 14% quarter-over-quarter to $2.18B.
Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.